Similar to the RISUG® technology in advanced clinical trials in India, Vasalgel™ is a polymer gel injected into the vas deferens, rather than cutting the vas (as is done in vasectomy). Its main advantage over vasectomy: It is hoped that like RISUG in India, it will be more readily reversible than vasectomy: if a man wishes to restore fertility, whether after months or years, the polymer would be flushed out of the vas with another injection. This method could thus be ideal for men who think they are finished having children but would like the chance to change their minds in case of remarriage or the death of a child—and it could possibly even be appropriate for men who want child-spacing or young men who want to complete their schooling before having children.
Development of this new polymer has to start at the beginning, but it is moving fast! Researchers have 12 months of successful results in rabbits already, and the goal is to have it on the market as an alternative to vasectomy as early as 2016, with a first clinical trial beginning in 2015.
Vasalgel is being developed as a “social venture,” a company that makes enough money to stay afloat but not to make anybody rich, with affordable pricing and wide availability as its mandate. The foundation sponsoring it is moving fast on getting the first steps done, with rabbit studies completed and a study in baboons just started, but won’t have enough money to finish the project and will be turning to the public to crowdfund the clinical trials. You can help!
To get updates on Vasalgel’s progress in the U.S. and any clinical trials, to be notified of opportunities to contribute, or to express interest in financially supporting or investing in the social venture, see ParsemusFoundation.org.
Want to let funders know that development of new methods for men is important to you and they should make it a priority? Complete our short, no-spam survey/petition.
Still have questions? See Vasalgel FAQ.